Bases of respiratory pharmacologyPhysiological and Cellular Fundamentals

Salbutamol and TerbutalineShort-Acting $\beta_2$-Adrenergic Agonists (SABA)

Salmeterol, Formoterol, Indacaterol, Olodaterol and Vilanterol$\beta_2$-Adrenergic Agonists with Prolonged and Ultra-Prolonged Action

Ipratropium bromideShort Acting Muscarinic Antagonists (SAMA)

Tiotropium Bromide, Glycopyrronium, Aclidinium and UmeclidiniumLong-Acting Muscarinic Antagonists (LAMA)

Fluticasone, Budesonide, Beclomethasone and CiclesonideInhaled Glucocorticoids (ICS)

Prednisone, Methylprednisolone, Hydrocortisone and DexamethasoneSystemic Glucocorticoids in Pulmonology

ICS/LABA, LAMA/LABA and Triple Therapy Associations (LAMA/LABA/ICS)Combination Therapies in a Single Device

Theophylline and AminophyllineMethylxanthines

Montelukast, Zafirlukast and ZileutónLeukotriene Receptor Antagonists (LTRA)

Disodium Cromoglycate and Sodium NedocromilChromones and Mast Cell Stabilizers

Omalizumab (Anti-IgE)Directed Biological Therapies (Part I)

Biologicals Anti-IL5 (Mepolizumab, Reslizumab), Anti-IL5R$\alpha$ (Benralizumab) and Anti-IL4R$\alpha$ (Dupilumab)Directed Biological Therapies (Part II)

Tezepelumab (Anti-TSLP)Third Generation Biologicals (Alarminas)

N-Acetylcysteine, Erdocysteine, Dornase Alfa and Poractant AlfaMucolytics, Expectorants and Pulmonary Surfactants

Codeine, Dextromethorphan, Cloperastine and LevodropropizineAntitussive Drugs

Sildenafil, Bosentan, Ambrisentan, Epoprostenol and RiociguatDrugs for Pulmonary Arterial Hypertension (PAH)

Nintedanib and PirfenidoneAntifibrotic Drugs in DILD

Integration and Clinical PracticeIntegrated Analysis, Clinical Cases and Adjustment Algorithms

Respiratory